Position in ELAN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,011
+$2,049 QoQ
Shares Held
163
+98.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#452
of 515 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $298,057 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,319 | $112,447 | |
| 2 | HLN |
Haleon plc
|
7,663 | $71,495 | |
| 3 | VTRS |
Viatris Inc
|
3,561 | $56,548 | |
| 4 | ZTS |
Zoetis Inc.
|
596 | $42,828 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
11 | $5,960 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
27 | $4,550 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
163 | $4,011 | |
| 8 | PRGO |
PERRIGO Co plc
|
21 | $218 |
All Filings in ELAN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,011 | 163 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,962 | 82 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,855 | 82 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,651 | 82 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,170 | 82 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $504 | 48 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||